TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Kamada ( (IL:KMDA) ) has shared an announcement.
Kamada Ltd. announced it will hold its Annual General Meeting of Shareholders on December 10, 2025, in Rehovot, Israel. The meeting will address several key proposals, including the re-election of board members, approval of options for the CEO, amendments to the compensation policy, and changes to the Articles of Association to enhance indemnification and insurance for directors and officers. Additionally, the re-appointment of Kost Forer Gabbay & Kasierer as independent auditors will be ratified. These decisions are crucial for maintaining corporate governance and ensuring compliance with Israeli laws, potentially impacting shareholder value and the company’s operational framework.
The most recent analyst rating on (IL:KMDA) stock is a Buy with a ILs11.00 price target. To see the full list of analyst forecasts on Kamada stock, see the IL:KMDA Stock Forecast page.
More about Kamada
Kamada Ltd. operates in the biopharmaceutical industry, focusing on the development, production, and marketing of specialty plasma-derived protein therapeutics. The company is based in Rehovot, Israel, and is known for its innovative treatments for rare and serious conditions.
Average Trading Volume: 48,118
Technical Sentiment Signal: Buy
Current Market Cap: ILs1.32B
For detailed information about KMDA stock, go to TipRanks’ Stock Analysis page.